[Cerebral hypersensitivity vasculitis].
Berek
K
K
Universitätsklinik für Neurologie, Innsbruck, Osterreich.
Maier
H
H
Aichner
F
F
Pfausler
B
B
Kofler
M
M
Gerstenbrand
F
F
D001921:Brain / Q000473:pathology; D001925:Brain Damage, Chronic / Q000473:pathology*; D002536:Cerebral Arteries / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000139:chemically induced / Q000473:pathology*; D004342:Drug Hypersensitivity / Q000473:pathology*; D006801:Humans; D002534:Hypoxia, Brain / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D013449:Sulfonamides / Q000009:adverse effects*; D014657:Vasculitis / Q000139:chemically induced / Q000473:pathology*
D013449:Sulfonamides
Zerebrale Hypersensitivitätsvaskulitis.